Goldman Sachs Upgrades SXC Health Solutions (SXCI) to Buy, Sees 19% Upside

March 9, 2012 6:52 AM EST Send to a Friend
Get Alerts SXCI Hot Sheet
Price: $93.02 --0%

Rating Summary:
    13 Buy, 6 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade SXCI Now!
Join SI Premium – FREE
Goldman Sachs upgraded SXC Health Solutions (NASDAQ: SXCI) to Buy with a price target of $86 (up from $71), suggesting 19% upside.

The firm said SXC Health will benefit meaningfully near-term in the current selling season and they see opportunity as it is still underappreciated despite positive EPS revision and recent stock outperformance.

As the company has grown revenue almost 6X over the 3 years, Goldman sees it more than doubling revenue by 2015.

For an analyst ratings summary and ratings history on SXC Health Solutions click here. For more ratings news on SXC Health Solutions click here.

Shares of SXC Health Solutions closed at $72.54 yesterday.




You May Also Be Interested In


Related Categories

Analyst PT Change, Upgrades

Related Entities

Goldman Sachs

Add Your Comment